Study: NCT05303961

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: SA001 240mg + Rebamipide 200mg or Placebo
Description: Cohort 1 in the Part1(Single dose): Study drug(SA001 240mg + Rebamipide 200mg), Comparator: Placebo

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: SA001 240mg + Rebamipide 200mg or Placebo
Description: Cohort 1 in the Part1(Single dose): Study drug(SA001 240mg + Rebamipide 200mg), Comparator: Placebo

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SA001 240mg + Rebamipide 200mg or Placebo
Description: Cohort 1 in the Part1(Single dose): Study drug(SA001 240mg + Rebamipide 200mg), Comparator: Placebo

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: SA001 480mg or Placebo
Description: Cohort 2 in the Part1(Single dose): Study drug(SA001 480mg), Comparator(Placebo)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SA001 480mg or Placebo
Description: Cohort 2 in the Part1(Single dose): Study drug(SA001 480mg), Comparator(Placebo)

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: SA001 710mg + Rebamipide 600mg or Placebo
Description: Cohort 3 in the Part1(Single dose): Study drug(SA001 720mg + Rebamipide 600mg), Comparator(Placebo)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: SA001 710mg + Rebamipide 600mg or Placebo
Description: Cohort 3 in the Part1(Single dose): Study drug(SA001 720mg + Rebamipide 600mg), Comparator(Placebo)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SA001 710mg + Rebamipide 600mg or Placebo
Description: Cohort 3 in the Part1(Single dose): Study drug(SA001 720mg + Rebamipide 600mg), Comparator(Placebo)

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: SA001 1,080mg or Placebo
Description: Cohort 4 in the Part1(Single dose): Study drug(SA001 1,080mg), Comparator(Placebo)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SA001 1,080mg or Placebo
Description: Cohort 4 in the Part1(Single dose): Study drug(SA001 1,080mg), Comparator(Placebo)

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: SA001 360mg or Placebo
Description: Cohort 5 in the Part2(Multiple dose): Study drug(SA001 360mg), Comparator(Placebo)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SA001 360mg or Placebo
Description: Cohort 5 in the Part2(Multiple dose): Study drug(SA001 360mg), Comparator(Placebo)

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: SA001 720mg or Placebo
Description: Cohort 6 in the Part2(Multiple dose): Study drug(SA001 720mg), Comparator(Placebo)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SA001 720mg or Placebo
Description: Cohort 6 in the Part2(Multiple dose): Study drug(SA001 720mg), Comparator(Placebo)

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: SA001 1,080mg or Placebo
Description: Cohort 7 in the Part2(Multiple dose): Study drug(SA001 1,080mg), Comparator(Placebo)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SA001 1,080mg or Placebo
Description: Cohort 7 in the Part2(Multiple dose): Study drug(SA001 1,080mg), Comparator(Placebo)